Johnson & Johnson, Sanofi and AstraZeneca are among the strategic buyers snatching up healthcare and pharmaceutical targets; meanwhile former KKR exec Jim Mmntazee has opened up a new PE firm focused on the sector
To read the entire story, you must be logged in.
Please log in now or register with us.
